Emerging and Under-Recognized Fibroblastic Tumors of the Skin and Subcutis: A Review Highlighting New Entities and Diagnostic Pitfalls
Authors:
- 16 November 2026
- journal article
- review article
- Published by SAGE Publications in International Journal of Surgical Pathology
Abstract
Tumor types and novel molecular alterations are being described at an accelerating rate, leading to rapid evolution of the classification system. There have been several recent developments in the classification of superficial fibroblastic and myofibroblastic tumor types, and, accordingly, there have been newly discovered pitfalls relevant to dermatopathology. Here, we survey new developments in the diagnosis and molecular pathogenesis of fibroblastic and myofibroblastic neoplasms of the skin and subcutis. Plexiform myofibroblastoma is a benign tumor type with plexiform architecture that can mimic the more aggressive plexiform fibrohistiocytic tumor. PLAG1 -rearranged fibromyxoid tumor is possibly related to lipoblastoma, occurs in superficial sites, and can mimic low-grade fibromyxoid sarcoma and spindle cell rhabdomyosarcoma. Superficial ALK -rearranged myxoid spindle cell neoplasm is a recently described cutaneous tumor type that can be mistaken for dermatofibrosarcoma protuberans (DFSP), and recent evidence suggests it is on a biologic spectrum with epithelioid fibrous histiocytoma. Similarly, plaque-like CD34-positive dermal fibroma and related NTRK - or ALK- rearranged plaque-like dermal neoplasms represent an expanding group of superficially located CD34-positive spindle cell tumors that may mimic DFSP. Nodular necrotizing fibroblastic tumor is a recently described, typically indolent tumor type that often occurs in skin and subcutis, harbors YAP1 :: MAML2 fusions, and closely mimics myxoinflammatory fibroblastic sarcoma. In addition to these new entities, we discuss some likely under-recognized tumor types that present pitfalls, including fibroblastic connective tissue nevus, which can mimic DFSP, and superficial CD34-positive pleomorphic fibroblastic tumor, which can mimic pleomorphic sarcoma. Collectively, these entities necessitate integrated histologic, immunohistochemical, and, sometimes, molecular evaluation to ensure accurate diagnosis and to avoid overtreatment.This publication has 85 references indexed in Scilit:
- A Clinicopathologic and Molecular Reappraisal of Myxoinflammatory Fibroblastic Sarcoma—A Controversial and Pathologically Challenging Low‐Grade SarcomaGenes, Chromosomes and Cancer, 2025
- Fibromyxoid aSoft Tissue Tumor With PLAG1 Fusion—The First Case in an Adult PatientGenes, Chromosomes and Cancer, 2024
- Identification of a novel SH3PXD2B::FER fusion in a case of plexiform myofibroblastic tumor and review of the literatureGenes, Chromosomes and Cancer, 2024
- Malignant undifferentiated epithelioid neoplasms with MAML2 rearrangements: A clinicopathologic study of seven cases demonstrating a heterogenous entityGenes, Chromosomes and Cancer, 2023
- ALK‐rearranged Mesenchymal Neoplasms: A Report of 9 cases Further Expanding the Clinicopathologic Spectrum of Emerging Kinase Fusion Positive Group of TumorsGenes, Chromosomes and Cancer, 2022
- Molecular investigation of ALK‐rearranged epithelioid fibrous histiocytomas identifies CLTC as a novel fusion partner and evidence of fusion‐independent transcription activationGenes, Chromosomes and Cancer, 2022
- Novel morphologic findings in PLAG1‐rearranged soft tissue tumorsGenes, Chromosomes and Cancer, 2021
- Pediatric fibromyxoid soft tissue tumor with PLAG1 fusion: A novel entity?Genes, Chromosomes and Cancer, 2020
- PRRX‐NCOA1/2 rearrangement characterizes a distinctive fibroblastic neoplasmGenes, Chromosomes and Cancer, 2019
- Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumorGenes, Chromosomes and Cancer, 2011